{
    "clinical_study": {
        "@rank": "8081", 
        "acronym": "SHE", 
        "arm_group": [
            {
                "arm_group_label": "Hypereosinophilic syndrome unexplained", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Hypereosinophilic syndrome explained", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Normal rate of eosinophilic", 
                "arm_group_type": "Sham Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose is to characterize new hypereosinophilic syndrome biomarkers more informative\n      and more accessible compared to those that we have already thanks to a proteomic approach.\n      This will help the investigators to diagnose the this disease."
        }, 
        "brief_title": "Identification of New Markers in the Hypereosinophilic Syndrome", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypereosinophilic Syndrome", 
        "condition_browse": {
            "mesh_term": "Hypereosinophilic Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  dated and signed informed consent\n\n          -  virale serology negative or negative result less than 6 months\n\n          -  virale serology negative for HBV or vaccinated patient\n\n          -  insured\n\n          -  virale serology negative or negative result less than 6 months\n\n          -  negative pregnancy test or female menopause for at least 1 year\n\n        Exclusion Criteria:\n\n          -  subject enable adult, under guardianship or under protective measures of justice\n\n          -  Refusal or inability to give informed consent\n\n          -  The hypereosinophilic syndrome explained origin other than  than atopy, bullous\n             pemphigoid, the Churg-Strauss syndrome and DRESS"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01713504", 
            "org_study_id": "CHRU of Lille"
        }, 
        "intervention": {
            "arm_group_label": [
                "Hypereosinophilic syndrome unexplained", 
                "Hypereosinophilic syndrome explained", 
                "Normal rate of eosinophilic"
            ], 
            "description": "comparison of biomarkers between HES, HE biomarkers data and control arms", 
            "intervention_name": "biologie sample", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 23, 2012", 
        "location": {
            "contact": {
                "email": "l-prin@hru-lille.fr", 
                "last_name": "Lionel Prin, MD PhD", 
                "phone": "(33)320 445 574"
            }, 
            "facility": {
                "address": {
                    "city": "Lille", 
                    "country": "France", 
                    "state": "Nord", 
                    "zip": "59037"
                }, 
                "name": "University hospital"
            }, 
            "investigator": {
                "last_name": "Pierre-Yves Hatron, MD PhD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "3", 
        "official_title": "Identification of New Markers in the Hypereosinophilic Syndrome", 
        "overall_contact": {
            "email": "l-prin@chru-lille.fr", 
            "last_name": "Lionel Prin, MD PhD", 
            "phone": "(33)320 445 574"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Lille", 
            "last_name": "Lionel Prin, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The aim is to characterize, through an approach immunoprot\u00e9omique, new HES biomarkers more informative and easier access than those currently available to us. These biomarkers will help to the diagnosis of HES, compared with other causes of eosinophilia.", 
            "safety_issue": "Yes", 
            "time_frame": "one month after patient inclusion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01713504"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Hospital, Lille", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Lille", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2010", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "June 2009"
    }
}